JP2020189845A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2020189845A5 JP2020189845A5 JP2020127888A JP2020127888A JP2020189845A5 JP 2020189845 A5 JP2020189845 A5 JP 2020189845A5 JP 2020127888 A JP2020127888 A JP 2020127888A JP 2020127888 A JP2020127888 A JP 2020127888A JP 2020189845 A5 JP2020189845 A5 JP 2020189845A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- composition according
- fibrosis
- inhibitor
- substituted
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2022199857A JP2023030022A (ja) | 2015-07-30 | 2022-12-15 | 線維症の処置 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AU2015903035 | 2015-07-30 | ||
| AU2015903035A AU2015903035A0 (en) | 2015-07-30 | Fibrotic treatment | |
| JP2018504650A JP2018527330A (ja) | 2015-07-30 | 2016-07-29 | 線維症の処置 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018504650A Division JP2018527330A (ja) | 2015-07-30 | 2016-07-29 | 線維症の処置 |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022199857A Division JP2023030022A (ja) | 2015-07-30 | 2022-12-15 | 線維症の処置 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2020189845A JP2020189845A (ja) | 2020-11-26 |
| JP2020189845A5 true JP2020189845A5 (cg-RX-API-DMAC10.html) | 2021-04-01 |
| JP7457360B2 JP7457360B2 (ja) | 2024-03-28 |
Family
ID=57883919
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018504650A Withdrawn JP2018527330A (ja) | 2015-07-30 | 2016-07-29 | 線維症の処置 |
| JP2020127888A Active JP7457360B2 (ja) | 2015-07-30 | 2020-07-29 | 線維症の処置 |
| JP2022199857A Pending JP2023030022A (ja) | 2015-07-30 | 2022-12-15 | 線維症の処置 |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018504650A Withdrawn JP2018527330A (ja) | 2015-07-30 | 2016-07-29 | 線維症の処置 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022199857A Pending JP2023030022A (ja) | 2015-07-30 | 2022-12-15 | 線維症の処置 |
Country Status (8)
| Country | Link |
|---|---|
| US (5) | US10100311B2 (cg-RX-API-DMAC10.html) |
| EP (1) | EP3328384B1 (cg-RX-API-DMAC10.html) |
| JP (3) | JP2018527330A (cg-RX-API-DMAC10.html) |
| AU (1) | AU2016301113B2 (cg-RX-API-DMAC10.html) |
| CA (1) | CA3017028C (cg-RX-API-DMAC10.html) |
| HK (1) | HK1256423A1 (cg-RX-API-DMAC10.html) |
| SG (1) | SG11201808478RA (cg-RX-API-DMAC10.html) |
| WO (1) | WO2017015720A1 (cg-RX-API-DMAC10.html) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US11306066B2 (en) * | 2015-05-08 | 2022-04-19 | Monash University | 4H-pyran compounds as insulin-regulated aminopeptidase (IRAP) inhibitors |
| WO2017015720A1 (en) * | 2015-07-30 | 2017-02-02 | Monash University | Fibrotic treatment |
| CN111163793A (zh) * | 2017-07-17 | 2020-05-15 | 莫纳什大学 | 血管紧张素受体激动剂及其用途 |
| JP2022516611A (ja) * | 2018-12-28 | 2022-03-01 | ザ ジェネラル ホスピタル コーポレイション | 線維性疾患の治療のための抗エフリン－ｂ２遮断抗体 |
| WO2021050089A1 (en) * | 2019-09-09 | 2021-03-18 | Washington State University | Genetic test for identifying cats at a high risk for developing tubulointerstitial fibrosis |
| TW202143994A (zh) | 2020-02-19 | 2021-12-01 | 美商希皮恩製藥公司 | 環孢素類似物於治療纖維化之用途 |
| WO2023099589A1 (en) * | 2021-12-01 | 2023-06-08 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Irap inhibitors for use in the treatment of inflammatory diseases |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2579768A1 (en) * | 2004-09-09 | 2006-03-16 | Howard Florey Institute Of Experimental Physiology And Medicine | Enzyme inhibitors and uses thereof |
| BRPI0615439A2 (pt) * | 2005-08-23 | 2011-05-17 | Wyeth Corp | métodos para o tratamento de ansiedade e para identificação de agentes ansiolìticos |
| US8263775B2 (en) * | 2007-11-19 | 2012-09-11 | Howard Florey Institute | Insulin-regulated aminopeptidase (IRAP) inhibitors and uses thereof |
| JP2015504870A (ja) * | 2011-12-16 | 2015-02-16 | タリックス ファーマシューティカルズ リミテッド | 線維症を処置するためのアンジオテンシン |
| CA2861521A1 (en) * | 2012-02-06 | 2013-08-15 | Glaxosmithkline Intellectual Property (No.2) Limited | Novel use |
| JP6327923B2 (ja) | 2014-04-25 | 2018-05-23 | 旭化成株式会社 | ポリアセタール樹脂組成物、及びそれからなる成形体 |
| DE102014114090A1 (de) | 2014-09-29 | 2016-03-31 | Karlsruher Institut für Technologie | Verfahren zur Abtrennung von Aluminium bei der Calciumsilikatproduktion |
| US9519061B2 (en) * | 2014-12-26 | 2016-12-13 | Here Global B.V. | Geometric fingerprinting for localization of a device |
| US11306066B2 (en) * | 2015-05-08 | 2022-04-19 | Monash University | 4H-pyran compounds as insulin-regulated aminopeptidase (IRAP) inhibitors |
| WO2017015720A1 (en) * | 2015-07-30 | 2017-02-02 | Monash University | Fibrotic treatment |
-
2016
- 2016-07-29 WO PCT/AU2016/050681 patent/WO2017015720A1/en not_active Ceased
- 2016-07-29 AU AU2016301113A patent/AU2016301113B2/en active Active
- 2016-07-29 EP EP16829507.9A patent/EP3328384B1/en active Active
- 2016-07-29 US US15/747,697 patent/US10100311B2/en active Active
- 2016-07-29 CA CA3017028A patent/CA3017028C/en active Active
- 2016-07-29 HK HK18115556.4A patent/HK1256423A1/zh unknown
- 2016-07-29 SG SG11201808478RA patent/SG11201808478RA/en unknown
- 2016-07-29 JP JP2018504650A patent/JP2018527330A/ja not_active Withdrawn
-
2018
- 2018-09-06 US US16/123,898 patent/US10787668B2/en active Active
-
2020
- 2020-07-29 JP JP2020127888A patent/JP7457360B2/ja active Active
- 2020-08-04 US US16/984,996 patent/US11078488B2/en active Active
-
2021
- 2021-07-01 US US17/365,260 patent/US11834663B2/en active Active
-
2022
- 2022-12-15 JP JP2022199857A patent/JP2023030022A/ja active Pending
-
2023
- 2023-10-26 US US18/495,512 patent/US20240084308A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2018527330A5 (cg-RX-API-DMAC10.html) | ||
| JP6526306B2 (ja) | バルドキソロンメチルまたはその類似体を使用して内皮機能障害を処置および予防する方法 | |
| JP4692281B2 (ja) | 新規アゾール化合物 | |
| JP3187535B2 (ja) | 医薬的に活性なヒドラジン誘導体およびその製造方法 | |
| BR122018015003B1 (pt) | kit compreendendo composições farmacêuticas de inibidor da nep e de valsartan ou seus sais | |
| JP2023030022A5 (cg-RX-API-DMAC10.html) | ||
| JP7457360B2 (ja) | 線維症の処置 | |
| JPWO2002092068A1 (ja) | カルボン酸誘導体化合物およびそれらを有効成分とする薬剤 | |
| WO2007083689A1 (ja) | プラスミノーゲンアクチベーターインヒビター－１阻害剤 | |
| JP2021519312A (ja) | カルパインモジュレーター及びその治療的使用 | |
| JPH08508720A (ja) | ピロールーアミジン化合物およびその薬剤的に受容できる塩、その製造法ならびにこれを含む医薬組成物 | |
| EP4072561A1 (en) | Methods of treating cancer | |
| JPH10130144A (ja) | アルツハイマー病の治療および予防用の医薬を製造するための非ペプチドのブラジキニンアンタゴニストの使用 | |
| US10358447B2 (en) | Substituted 2-N-hydroxy-1,3-dioxo-1,2,3,4-tetrahydronaphthyridines, and methods of making and using same | |
| JP2023505598A (ja) | 化合物及びα１－アンチトリプシン欠損症の治療のためのそれらの使用 | |
| Lu et al. | Design, synthesis, and evaluation of pirfenidone-NSAIDs conjugates for the treatment of idiopathic pulmonary fibrosis | |
| JP2011506363A (ja) | 心不全の処置および／または予防用のオキサゾリジノン類 | |
| US20050130941A1 (en) | Methods of treating alzheimer's disease | |
| JP2007131532A (ja) | 生体内リン輸送を阻害する化合物およびそれを含んでなる医薬 | |
| JP2002544119A (ja) | フェニルアラニン誘導体 | |
| TW201215389A (en) | Sustained-release therapeutic agent for hypertension and renal dysfunction | |
| JPH0529209B2 (cg-RX-API-DMAC10.html) | ||
| WO2017170860A1 (ja) | ヒートショックプロテイン４７阻害剤 | |
| US20210260153A1 (en) | Use of cyclosporine analogues for treating fibrosis | |
| JP2003528850A (ja) | 血管形成および腫瘍成長の阻害 |